Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef
Gaming und Metaverse zieht nicht nur Spieler an

Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden

Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef
Gaming und Metaverse zieht nicht nur Spieler an

Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden

Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef
Gaming und Metaverse zieht nicht nur Spieler an

Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden

Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef
Gaming und Metaverse zieht nicht nur Spieler an

Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden

Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an

Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln

SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023

Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an

Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln

SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023

Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an

Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln

SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023

PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg
PayPal's Comeback An Undervalued Investment Opportunity

PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the

PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg
PayPal's Comeback An Undervalued Investment Opportunity

PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the

PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg
PayPal's Comeback An Undervalued Investment Opportunity

PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the

Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023

Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month. 

Nasdaq announced the rebalance on Friday, July 7, after the

Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023

Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month. 

Nasdaq announced the rebalance on Friday, July 7, after the

Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023

Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month. 

Nasdaq announced the rebalance on Friday, July 7, after the

Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023

Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month. 

Nasdaq announced the rebalance on Friday, July 7, after the

Fortinet Positioned For Growth In AI-Based Cybersecurity Boom: https://www.valuewalk.com/wp-content/uploads/2023/05/Cyber-Insurance-300x150.jpeg
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom

Key Points

  • Cybersecurity spending on enterprise information security is projected to grow rapidly, driven by factors such as AI.
  • Fortinet stands out as the cybersecurity stock with the best
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom: https://www.valuewalk.com/wp-content/uploads/2023/05/Cyber-Insurance-300x150.jpeg
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom

Key Points

  • Cybersecurity spending on enterprise information security is projected to grow rapidly, driven by factors such as AI.
  • Fortinet stands out as the cybersecurity stock with the best
Zenocutuzumab (Zeno) erhält zweiten Status als zukunftsweisende Therapie von der US-amerikanischen Food and Drug Administration
Zenocutuzumab (Zeno) erhält zweiten Status als zukunftsweisende Therapie von der US-amerikanischen Food and Drug Administration

– Zeno erhält Status als zukunftsweisende Therapie für die Behandlung von nicht-kleinzelligem NRG1+-Lungenkrebs

UTRECHT, Niederlande und CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) --

The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg
The Top Stocks Sold by Institutional Investors

An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of

The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg
The Top Stocks Sold by Institutional Investors

An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of

The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg
The Top Stocks Sold by Institutional Investors

An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of

The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg
The Top Stocks Sold by Institutional Investors

An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of

Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud

Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a

Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud

Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a

Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud

Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a

Zenocutuzumab (Zeno) erhält Status als zukunftsweisende Therapie für die Behandlung von NRG1+-Bauchspeicheldrüsenkrebs von der US-amerikanischen Food and Drug Administration
Zenocutuzumab (Zeno) erhält Status als zukunftsweisende Therapie für die Behandlung von NRG1+-Bauchspeicheldrüsenkrebs von der US-amerikanischen Food and Drug Administration

UTRECHT, Niederlande und CAMBRIDGE, Mass., June 30, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein im klinischen Stadium tätiges Onkologieunternehmen, das innovative multispezifische